Weight Gain May Follow Head and Neck Cancer Operations

Overweight and obesity may be a new challenge in the care of patients with oropharyngeal squamous cell carcinoma.
Overweight and obesity may be a new challenge in the care of patients with oropharyngeal squamous cell carcinoma.

Overweight and obesity may be a new challenge in the care of patients with oropharyngeal squamous cell carcinoma (OPSCC) and oral cavity squamous cell carcinoma (OCSCC), a new study published online ahead of print in the journal Supportive Care in Cancer has suggested.1

Because the incidence of human papillomavirus (HPV)-related head and neck cancer has been increasing and treatment regimens have been changing, researchers sought to evaluate whether treatment-related weight changes in patients with head and neck cancer has also been evolving.

For the retrospective cohort study, researchers analyzed data on pre- and posttreatment body weight, demographics, medical history, and treatments from 290 patients with OPSCC or OCSCC who received initial definitive treatment at the University of Pennsylvania.

Results showed over 70% of patients with OPSCC and OCSCC were overweight or obese at all pre- and posttreatment assessments. Researchers found that patients with OPSCC had a 6.63-kg higher average weight than patients with OCSCC at all assessments (P=.002).

After adjusting for potential confounding factors, the study demonstrated that patients who underwent a primary operation had significantly more weight gain from pretreatment to posttreatment follow-up compared with those who underwent primary radiotherapy and/or chemotherapy (P=.041).

Further study is needed to evaluate whether exercise and nutritional interventions can improve their survivorship,” the authors conclude.

REFERENCE

1. Zhang Z, Brown JC, O'Malley BW, et al. Post-treatment weight change in oral cavity and oropharyngeal squamous cell carcinoma [published online ahead of print December 1, 2015]. Supp Care Cancer. doi:10.1007/s00520-015-3029-6.

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs